Virginia L. Brunetto

Author

Roswell Park Comprehensive Cancer Center

Also Known As

V L Brunetto, V. L. Brunetto, Virginia L Brunetto, Virginia L. Brunetto, Virginia L. Brunetto (Filiaci)

Publications

3.5K

Citations

H-Index

Concepts

All Affiliations

Roswell Park Comprehensive Cancer Center Gynecologic Oncology Group Penn State Milton S. Hershey Medical Center Wake Forest University Pennsylvania State University

About

Virginia L. Brunetto is an author at Roswell Park Comprehensive Cancer Center specializing in gynecology oncology, oncology, and obstetrics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	2.4K
2	Obstetrics	7	7	2.4K
3	Surgical Oncology	3	3	1.8K
4	Public Health	1	1	130
5	Pathology	1	1	74

Virginia L. Brunetto

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a Gynecologic Oncology Group study Henry Keys, James A. Roberts, Virginia L. Brunetto, Gynecologic Oncology Gynecologic SurgerySurgical OncologyGynecological SurgeryRadiation TherapyMedicine	2004	1.6K
Phase III Trial of Doxorubicin Plus Cisplatin With or Without Paclitaxel Plus Filgrastim in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study Gini F. Fleming, Virginia L. Brunetto, David Cella, Journal of Clinical Oncology	2004	561
A Phase III Trial of Ifosfamide with or without Cisplatin in Carcinosarcoma of the Uterus: A Gynecologic Oncology Group Study Gregory P. Sutton, Virginia L. Brunetto, Larry C. Kilgore, Gynecologic Oncology MedicinePhase Iii TrialGynecologyCancer TreatmentOncology	2000	257
A Phase II Trial of Anastrozole in Advanced Recurrent or Persistent Endometrial Carcinoma: A Gynecologic Oncology Group Study Peter G. Rose, Virginia L. Brunetto, Linda Vanle, Gynecologic Oncology Advanced RecurrentPhase Ii TrialMedicineGynecologyOncology	2000	201
An Analysis of Cell Type in Patients with Surgically Staged Stage IB Carcinoma of the Cervix: A Gynecologic Oncology Group Study Katherine Y. Look, Virginia L. Brunetto, Daniel L. Clarke‐Pearson, Gynecologic Oncology	1996	151
A Phase III Trial of Surgery With or Without Adjunctive External Pelvic Radiation Therapy in Intermediate-Risk Endometrial Adenocarcinoma: A Gynecologic Oncology Group Study Henry Keys, James A. Roberts, Virginia L. Brunetto, Obstetrical & Gynecological Survey Surgical OncologyCancer ManagementEpidemiology Of CancerGynecologySurgery	2004	130
Randomized Phase III Trial of Standard Timed Doxorubicin Plus Cisplatin Versus Circadian Timed Doxorubicin Plus Cisplatin in Stage III and IV or Recurrent Endometrial Carcinoma: A Gynecologic Oncology Group Study Holly H. Gallion, Virginia L. Brunetto, Michael L. Cibull, Journal of Clinical Oncology	2003	117
Goserelin Acetate as Treatment for Recurrent Endometrial Carcinoma Robert F. Asbury, Virginia L. Brunetto, Roger B. Lee, American Journal of Clinical Oncology Goserelin AcetateMedicineCancer ManagementGynecologyPathology	2002	74
Villoglandular Adenocarcinoma of the Endometrium: A Clinicopathologic Study of 61 Cases Richard J. Zaino, Robert J. Kurman, Virginia L. Brunetto, The American Journal of Surgical Pathology	1998	66
Acute myeloid leukemia-type chemotherapy for newly diagnosed patients without antecedent cytopenias having myelodysplastic syndrome as defined by French-American-British criteria: a Cancer and Leukemia Group B Study. Steven H. Bernstein, Virginia L. Brunetto, Frederick R. Davey, Journal of Clinical Oncology	1996	56

Page 1